Wedbush Starts Tscan Therapeutics Inc (TCRX) at Outperform
Tweet
Share
E-mailGet Alerts TCRX Hot Sheet
Price: $8.66 -2.15%
Rating Summary:
8 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 21
Rating Summary:
8 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 21
Join SI Premium – FREE
Wedbush analyst David Nierengarten initiates coverage on Tscan Therapeutics Inc (NASDAQ: TCRX) with a Outperform rating and a price target of $8.00.
For an analyst ratings summary and ratings history on Tscan Therapeutics Inc click here. For more ratings news on Tscan Therapeutics Inc click here.
Shares of Tscan Therapeutics Inc closed at $2.83 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo Starts J.B. Hunt Transport Services (JBHT) at Overweight
- Morgan Stanley Starts AerCap Holdings (AER) at Equalweight
- BTIG Starts Upbound Group (UPBD) at Buy
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
